Japan Proposes Standards For Regenerative Medicine Equipment
This article was originally published in PharmAsia News
Japanese government ministries met to discuss standardization of regenerative medicine. Working groups paved the way towards standardization of cell culture process facilities and equipment.
You may also be interested in...
Biocon Biologics upbeat on Lantus follow-on’s long revenue stream and prospects for interchangeability, while operational challenges resulted in some supply constraints during the fiscal second quarter.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
For the first time, the US FDA granted an emergency use authorization to a device that allows for the home collection of saliva for COVID-19 diagnosis. See what Scott Rabuka, senior director of molecular products at DNA Genotek, which developed the test, said about it here.